Self‐Amplifying AIE Probe for HClO‐Activatable Imaging and Antioxidative/Anti‐Inflammatory Therapy of Thoracic Aortic Dissection
- 2 September 2026
- journal article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (43)
Abstract
Thoracic aortic dissection (TAD) is a highly lethal cardiovascular disease, yet its accurate diagnosis and effective treatment remain challenging due to poor imaging contrast and insufficient specificity. Leveraging the overexpressed reactive oxygen species (ROS) in TAD, we reported a hypochlorous acid (HClO)‐activatable molecular probe DT‐PZ. It enables two‐stage self‐amplifying fluorescence imaging (chemical activation and then physical aggregation) and light‐independent therapy on a single chemical entity. The probe initially exhibits quenched fluorescence via photoinduced electron transfer (PET). Two pathways can turn on the fluorescence via chemical activation: (1) oxidation by HClO blocks PET and turns on the emission; (2) photo‐triggered radicals generation of HClO (via chloride ions or myeloperoxidase) to activate neighboring probes, creating self‐amplifying fluorescence. Upon accumulation at the lesion site, the physical aggregation caused by the aggregation‐induced emission effect further amplifies the fluorescence signals. This two‐stage fluorescence amplification mechanism enables TAD visualization within 2 min in vivo. For therapy, the phenothiazine scavenges excess ROS during non‐illuminated periods, down‐regulates the NF‐κB/P65 signal pathway, and up‐regulates eNOS and P‐Akt expressions, protecting endothelial homeostasis and then improving murine survival from 50% to 90%. Collectively, DT‐PZ synergizes self‐amplifying fluorescence imaging with light‐independent antioxidation/anti‐inflammatory therapy, holding great promise for managing deep‐seated cardiovascular diseases.Keywords
Funding Information
- National Natural Science Foundation of China (22575184)
- National Natural Science Foundation of China (52203239)
- National Natural Science Foundation of China (U24A20523)
- National Natural Science Foundation of China (22475166)
- National Key Research and Development Program of China (2023YFB3810001)
This publication has 34 references indexed in Scilit:
- Engineering Coumarin‐Based Afterglow Luminescence Probes for Activatable Imaging Peroxynitrite In VivoAngewandte Chemie International Edition, 2026
- Achieving High‐Brightness NIR‐II Emission: Molecular Locking and Wrapping Strategies in Fluorescent Material Design for in Vivo BioimagingAdvanced Materials, 2025
- Access to Diverse Activatable Heptamethine Cyanine Probes with Low Intrinsic Fluorescence via 5‐ exo‐trig Cyclization Strategy for High‐Contrast Bioimaging In VivoAngewandte Chemie International Edition, 2025
- Near–Infrared Heptamethine Cyanine Photosensitizers with Efficient Singlet Oxygen Generation for Anticancer Photodynamic TherapyAngewandte Chemie International Edition, 2024
- Aggregation‐induced emission biomarkers for early detection of orthopaedic implant failureAggregate, 2024
- Ultrabright NIR AIEgen nanoparticles‐enhanced lateral flow immunoassay platform for accurate diagnostics of complex samplesAggregate, 2024
- A Highly Water‐Soluble Aggregation‐Induced Emission Luminogen with Anion‐π+ Interactions for Targeted NIR Imaging of Cancer Cells and Type I Photodynamic TherapyAngewandte Chemie International Edition, 2023
- Management of Thoracic Aortic DissectionJAMA, 2023
- A fluorescent nano vector for early diagnosis and enhanced Interleukin-33 therapy of thoracic aortic dissectionBiomaterials, 2022
- Bright and Stable NIR‐II J‐Aggregated AIE Dibodipy‐Based Fluorescent Probe for Dynamic In Vivo BioimagingAngewandte Chemie International Edition, 2020